Business Context and Reporting Period
This Form 6-K filing by Hang Feng Technology Innovation Co., Ltd. covers the period ending September 16, 2025. The report details the pricing, closing, and over-allotment exercise of the Company's Initial Public Offering (IPO).
Key Financial Metrics
- Shares Issued: 1,375,000 ordinary shares in the primary IPO; an additional 206,250 shares issued via the over-allotment option.
- Offering Price: $4.00 per share.
- Gross Proceeds: $5,500,000 (before underwriting discounts, commissions, and offering expenses).
- Trading Symbol: "FOFO" on The Nasdaq Capital Market.
- Underwriter: Kingswood Capital Partners, LLC (sole book-runner).
Material Changes
The filing represents a material change in the Company's capital structure and public status. The Company transitioned from a private entity to a public issuer following the IPO closing on September 15, 2025, and the full exercise of the over-allotment option on September 16, 2025. The filing text does not provide comparative financial data (revenue, profit, or cash flow) against prior periods as this is an IPO announcement rather than a periodic financial report.
Outlook and Management Commentary
Management commentary is limited to the announcement of the successful IPO pricing, closing, and the exercise of the over-allotment option. The Company issued press releases on September 12, 15, and 16, 2025, regarding these events. The filing does not contain specific forward-looking guidance, risk factors, or contingency details beyond standard legal disclaimers regarding the sale of securities.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses, as only gross proceeds are stated.
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up periods and indemnification terms.
- Confirm the total number of outstanding shares post-IPO to calculate accurate ownership dilution.
- Check the Company's Form F-1 (File No. 333-287284) for detailed financial statements and risk factors not included in this summary.